Melissa Tomkiel Sells 29,730 Shares of Strata Critical Medical (NASDAQ:SRTA) Stock

Strata Critical Medical (NASDAQ:SRTA) CEO Melissa Tomkiel sold 29,730 shares of the stock in a transaction on Monday, June 8th. The stock was sold at an average price of $5.87, for a total transaction of $174,515.10. Following the transaction, the chief executive officer directly owned 1,892,774 shares in the company, valued at approximately $11,110,583.38. This represents a 1.55% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Strata Critical Medical Stock Performance

NASDAQ SRTA traded down $0.12 on Wednesday, hitting $5.49. 1,306,162 shares of the company were exchanged, compared to its average volume of 874,584. The stock has a market capitalization of $475.05 million, a P/E ratio of -68.63 and a beta of 2.20. Strata Critical Medical has a 12 month low of $3.57 and a 12 month high of $6.50. The stock’s fifty day moving average is $5.14.

Strata Critical Medical (NASDAQ:SRTA) last released its quarterly earnings data on Wednesday, May 6th. The company reported $0.03 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.07. Strata Critical Medical had a net margin of 20.56% and a negative return on equity of 4.06%. The firm had revenue of $67.38 million for the quarter. As a group, research analysts anticipate that Strata Critical Medical will post -0.14 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the stock. Zacks Research raised shares of Strata Critical Medical to a “hold” rating in a research note on Thursday, March 26th. Craig Hallum assumed coverage on shares of Strata Critical Medical in a research note on Wednesday, March 25th. They issued a “buy” rating and a $8.00 price objective on the stock. B. Riley Financial assumed coverage on shares of Strata Critical Medical in a research note on Wednesday, March 25th. They issued a “buy” rating and a $8.00 price objective on the stock. Finally, Weiss Ratings raised shares of Strata Critical Medical from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, May 11th. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $8.00.

Institutional Trading of Strata Critical Medical

Several institutional investors and hedge funds have recently made changes to their positions in SRTA. Seelaus Asset Management LLC raised its holdings in shares of Strata Critical Medical by 32.7% in the first quarter. Seelaus Asset Management LLC now owns 24,350 shares of the company’s stock valued at $102,000 after purchasing an additional 6,000 shares during the last quarter. Granite Investment Partners LLC raised its holdings in shares of Strata Critical Medical by 77.0% in the first quarter. Granite Investment Partners LLC now owns 18,181 shares of the company’s stock valued at $76,000 after purchasing an additional 7,911 shares during the last quarter. Principal Financial Group Inc. purchased a new stake in shares of Strata Critical Medical in the first quarter valued at about $537,000. Dimensional Fund Advisors LP raised its holdings in shares of Strata Critical Medical by 11.9% in the first quarter. Dimensional Fund Advisors LP now owns 1,617,104 shares of the company’s stock valued at $6,759,000 after purchasing an additional 172,154 shares during the last quarter. Finally, Quantinno Capital Management LP raised its holdings in shares of Strata Critical Medical by 98.7% in the first quarter. Quantinno Capital Management LP now owns 143,239 shares of the company’s stock valued at $599,000 after purchasing an additional 71,155 shares during the last quarter. Hedge funds and other institutional investors own 47.36% of the company’s stock.

Strata Critical Medical Company Profile

Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.